Announcement on Progress of Signing of the Drug Marketing Authorization Transfer Contract by Controlled Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600420)"Shanghai Shyndec Pharmaceutical Co., Ltd."Announcement on Progress of Signing of the Drug Marketing Authorization Transfer Contract by Controlled Subsidiary
Filed with SSE · Stock code 600420 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Shanghai Shyndec Pharmaceutical Co., Ltd. on 6ix
Story so far
Earlier from Shanghai Shyndec Pharmaceutical
- (600420)"Shanghai Shyndec Pharmaceutical Co., Ltd."Announcement on Obtaining Drug Registration Certificate
- (600420)"Shanghai Shyndec Pharmaceutical Co., Ltd."Performance Forecast for the First Three Quarters of 2026
- Announcement on Progress of Provision of Guarantees by a Wholly-owned Subsidiary to Its Subordinate Enterprise
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
Follow Shanghai Shyndec Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Shyndec Pharmaceutical